Mia's Feed
Medical News & Research

Innovative Brain-Computer Interface Empowers Paralyzed Individuals to Personalize Touch Sensations

Innovative Brain-Computer Interface Empowers Paralyzed Individuals to Personalize Touch Sensations

Share this article

2 min read

Scientists from the University of Pittsburgh School of Medicine have taken a significant step forward in restoring tactile sensation for individuals with paralysis. They are developing a cutting-edge brain-computer interface (BCI) that enables users to customize and perceive a sense of touch, making interactions with objects more intuitive and meaningful.

This pioneering research, conducted in collaboration with the University of Chicago and detailed in Nature Communications, allows users with tetraplegia to digitally explore objects and receive tailored tactile feedback. Unlike earlier attempts, where artificial sensations were often vague and generic, this new approach grants users control over the specific features of the electrical stimulation that produce different tactile feelings.

Participants described their sensations as akin to feeling the warmth of a purring cat, the smooth surface of a key, or the coolness of an apple. They reported customizing the stimulation parameters until the sensations resembled those naturally associated with different objects, creating a more realistic and personalized sense of touch.

This innovative method involved a trial-and-error process, where users explored different stimulation settings in a virtual environment, akin to playing a game of 'hot and cold.' Although correct identification of objects was achieved only 35% of the time—better than chance—the ability to distinguish between tactile sensations marked an encouraging advancement.

Lead author Ceci Verbaarschot emphasized that designing their own tactile sensations helps foster interactions that feel more natural and engaging, a crucial step toward developing effective neuroprosthetics. These advancements could eventually lead to prosthetic limbs and assistive devices that provide users with a seamless and intuitive sense of touch, dramatically improving quality of life for individuals with paralysis.

Since the last decade, Pitt scientists have helped paralyzed individuals experience touch through brain-controlled robotic arms and have demonstrated improvements in movement efficiency with artificial sensory feedback. This new study signifies progress toward creating a sensory experience that is rich, diverse, and individualized, transforming the landscape of neurotechnology and rehabilitation.

Source: MedicalXpress

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Large Study Finds Statins Significantly Reduce Death Risk in Critical Sepsis Patients

A large cohort study reveals that statin therapy may lower the risk of death by 39% in critically ill sepsis patients, highlighting a promising adjunct treatment option. Learn more about the potential benefits of statins in sepsis management.

Maintenance Combination of Lurbinectedin and Atezolizumab Improves Survival in Lung Small Cell Carcinoma

A combination of lurbinectedin and atezolizumab as maintenance therapy significantly improves survival in extensive-stage small cell lung cancer, according to new research presented at ASCO 2025.

Rethinking Alcohol Policies: New Study Highlights Discrepancies in How Alcohol Is Discussed by Policymakers and the Public

A groundbreaking study reveals key differences in how policymakers and the public discuss alcohol, urging the development of emotionally informed and inclusive alcohol policies to effectively reduce harm.

New Therapeutic Target Identified to Prevent Breast Cancer Relapse by Eliminating Dormant Cells

Canadian scientists have identified PIK3C3 as a key protein for dormant breast cancer cell survival, paving the way for therapies to prevent metastasis and relapse. This breakthrough offers new hope for reducing recurrence and improving long-term outcomes for breast cancer patients.